Allisartan Isoproxil Improves Endothelial Function and Vascular Damage in Patients with Essential Hypertension: A Single-Center, Open-Label, Randomized Controlled Trial

Allisartan Isoproxil Improves Endothelial Function and Vascular Damage in Patients with Essential Hypertension: A Single-Center, Open-Label, Randomized Controlled Trial

The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite). © The authors, CC-BY-NC 2020.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Zhang, Gaoxing, Fan, Yongqiang, Qiu, Yumin, Zhou, Zhe, Zhang, Jianning, Wang, Zhichao, Liu, Yuanya, Liu, Xing, Tao, Jun
Format: Bild
Sprache:eng
Schlagworte:
Cardiology
Medicine
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite). © The authors, CC-BY-NC 2020.
DOI:10.6084/m9.figshare.12471605